A new research from the University of California, Irvine has revealed that loss of circadian regulation allows for increase in glucose production as lung cancer progresses. The study is titled “Glucagon regulates…
Author: Lung Cancer
What is Combination Therapy for Metastatic Lung Cancer?
Most of the times, lung cancer is found when it has already spread to other parts of the body. It may have travel to lymph nodes near or away from lung, the…
Managing Shortness of Breath among Lung Cancer Patients
Shortness of breath, also called dyspnea, is common with lung cancer patients and it often gets worse with advancement of disease. This trouble in breathing may be caused by growth of tumor,…
Study Suggests, Not to Delay Lung Cancer Surgery
According to a new study by researchers at Washington University School of Medicine in St. Louis, delaying lung cancer surgery for more than 12 weeks from the date of diagnosis with CT…
FDA Approves First Targeted Therapy for Lung Cancer with Specific Genetic Mutation
The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose tumors have specific type of genetic mutation called KRAS G12C. It is…
FDA Approves Rybrevant for Certain Patients with Non-Small Cell Lung Cancer
Lung cancer is a complex disease, accounting for almost 25% of all cancer deaths. The Food and Drug Administration (FDA) has approved Rybrevant for treatment of adults with non-small cell lung cancer…
Study: New Breath Test to Detect Lung Cancer
Lung cancer is the second most commonly diagnosed cancers. According to the World Health Organization, there were 2.2 million new lung cancer cases and 1.8 million people died from the disease in…
Topotecan–Berzosertib Combination Effective for SCLC Treatment
Researchers all over the world are continuously been working towards finding effective treatments and therapies for lung cancer. There are widely two types of lung cancer: small cell lung cancer (SCLC) and…